Website
News25/Ratings0
Latest news
25 items- SECSEC Form SEC STAFF ACTION filed by Novo Integrated Sciences Inc.SEC STAFF ACTION - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form NT 10-Q filed by Novo Integrated Sciences Inc.NT 10-Q - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form 10-K filed by Novo Integrated Sciences Inc.10-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- PRNovo Integrated Sciences Reports 2024 Fiscal Year Financial ResultsNovo Integrated Sciences, Inc. (OTC:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints providing services and product innovation, today reported its financial results for the fiscal year ended August 31, 2024. Robert Mattacchione, the Company's CEO and Board Chairman, stated, "The Company remains committed to the commercialization of its proprietary product offerings and the expansion and delivery of its essential services and solutions to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered both now and
- SECSEC Form NT 10-K filed by Novo Integrated Sciences Inc.NT 10-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form DEFA14A filed by Novo Integrated Sciences Inc.DEFA14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Other Events8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form DEFA14A filed by Novo Integrated Sciences Inc.DEFA14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update, Other Events8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Leadership Update8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form DEF 14A filed by Novo Integrated Sciences Inc.DEF 14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form PRE 14A filed by Novo Integrated Sciences Inc.PRE 14A - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- SECSEC Form S-8 filed by Novo Integrated Sciences Inc.S-8 - Novo Integrated Sciences, Inc. (0001138978) (Filer)
- INSIDERSEC Form 4 filed by Chief Operating Officer David Christopher Mehlin4 - Novo Integrated Sciences, Inc. (0001138978) (Issuer)
- SECNovo Integrated Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Novo Integrated Sciences, Inc. (0001138978) (Filer)